Anti-CENP-B antibodies are associated with prolonged survival in breast cancer.

Aims: Presence of a relationship between autoimmunity and malignant diseases has been investigated for a long time. Anti-SS-B and anti-centromere protein (CENP)-B antibodies are used as serologic markers for autoimmune diseases. In this study, these autoantibodies were studied in breast cancer patients, and their effect on survival was evaluated.

Neoplastic diseases prevalence in a turkish university hospital.

Purpose: The purpose of this study was to register the different cancer cases diagnosed in our hospital with an aim to define the most common and treatable cancer types and help define accurate targets for the allocation of the already limited resources of the Ministry of Health.

Materials And Methods: We surveyed 12 months of the hospital's pathology records to determine the prevalence of various cancer types.

Results: Out of 9720 biopsy and cytology samples, 662 were cancer cases.

What is the optimal number of lymph nodes to be dissected in colorectal cancer surgery?

Background: Regional lymph node (LN) involvement in colorectal cancer (CRC) identifies the stage and the subset of patients who would benefit from adjuvant chemotherapy. We performed a retrospective analysis to determine if the number of recovered LNs was associated with long-term outcome in patients operated on for stage II and III CRC.

Patients And Methods: Hospital records of 179 patients with CRC followed in our unit from 1997 to April 2003 were reviewed.

The role of anti-CENP-B and anti-SS-B antibodies in breast cancer.

A close relationship between autoimmunity and malignant diseases has been supposed for a long time. In clinical practice, anti-SS-B and anti-CENP-B antibodies are used as serologic markers for autoimmune diseases. In this study, anti-SS-B and anti-CENP-B autoantibodies were studied in breast cancer patients and compared to a control group surgically treated due to benign diseases.

Remaining controversies in the upfront management of advanced ovarian cancer.

Ovarian cancer (OC) is one of the leading causes of cancer-related death in women. In the last decades, a lot of energy and resources have been put into a number of clinical trials, with some success. Nevertheless, the prognosis of patients diagnosed with advanced disease remains extremely poor.